key: cord-0962031-4gr6i8rf
authors: Aguas, R.; Corder, R. M.; King, J. G.; Goncalves, G.; Ferreira, M. U.; M. Gomes, M. G.
title: Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics
date: 2020-07-24
journal: nan
DOI: 10.1101/2020.07.23.20160762
sha: f9989fce0ece5629bf577c22565981f6ced7a101
doc_id: 962031
cord_uid: 4gr6i8rf

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads, the susceptible subpopulation declines causing the rate at which new infections occur to slow down. Variation in individual susceptibility or exposure to infection exacerbates this effect. Individuals that are more susceptible or more exposed tend to be infected and removed from the susceptible subpopulation earlier. This selective depletion of susceptibles intensifies the deceleration in incidence. Eventually, susceptible numbers become low enough to prevent epidemic growth or, in other words, the herd immunity threshold is reached. Here we fit epidemiological models with inbuilt distributions of susceptibility or exposure to SARS-CoV-2 outbreaks to estimate basic reproduction numbers (R_0) alongside coefficients of individual variation (CV) and the effects of containment strategies. Herd immunity thresholds are then calculated as 1-(1/R_0 )^(1/((1+CV^2 ) )) or 1-(1/R_0 )^(1/((1+2CV^2 ) )), depending on whether variation is on susceptibility or exposure. Our inferences result in herd immunity thresholds around 10-20%, considerably lower than the minimum coverage needed to interrupt transmission by random vaccination, which for R_0 higher than 2.5 is estimated above 60%. We emphasize that the classical formula, 1-1/R_0 , remains applicable to describe herd immunity thresholds for random vaccination, but not for immunity induced by infection which is naturally selective. These findings have profound consequences for the governance of the current pandemic given that some populations may be close to achieving herd immunity despite being under more or less strict social distancing measures.

contact tracing, quarantine, and social distancing, to mitigate or suppress the initial 44 pandemic spread 1 . Successful suppression, however, may leave populations at risk to 45 resurgent waves due to insufficient acquisition of immunity. Models have thus also 46 addressed longer term SARS-CoV-2 transmission scenarios and the requirements for 47 continued adequate response 2 . This is especially timely as countries relax lockdown 48 measures that have been in place over recent months with varying levels of success in 49 tackling national outbreaks. 50

Here we demonstrate that individual variation in susceptibility or exposure 51 (connectivity) accelerates the acquisition of immunity in populations. More 52 susceptible and more connected individuals have a higher propensity to be infected 53 and thus are likely to become immune earlier. Due to this selective immunization by 54 natural infection, heterogeneous populations require less infections to cross their herd 55 immunity threshold (HIT) than suggested by models that do not fully account for 56 variation. We integrate continuous distributions of susceptibility or connectivity in 57 otherwise basic epidemic models for COVID-19 which account for realistic 58 intervention effects and show that as coefficients of variation (CV) increase from 0 to 59 5, HIT declines from over 60% 3,4 to less than 10%. We then fit these models to series 60 of daily new cases to estimate CV alongside basic reproduction numbers ( * ) and 61 derive the corresponding HITs. 62

Individual variation in susceptibility is integrated as a continuously distributed factor 67 that multiplies the force of infection upon individuals 5 as 68 

where ( ) is the number of individuals with susceptibility , ( ) and ( ) are the 73 numbers of individuals who originally had susceptibility and became exposed and 74 infectious, while ( ) counts those who have recovered and have their susceptibility 75 reduced to a reinfection factor due to acquired immunity. is the rate of 76 progression from exposed to infectious, is the rate of recovery or death, is the 77 proportion of individuals who die as a result of infection and ( ) = 78

is the average force of infection upon susceptible 79 individuals in a population of size and transmission coefficient . Standardizing so 80 that susceptibility distributions have mean ?∫ ( ) = 1, given a probability 81 density function ( ), the basic reproduction number is 82

where is a factor measuring the infectivity of individuals in compartment E in 84 relation to those in . The coefficient of variation in individual susceptibility = 85

?∫( − 1) + ( ) is explored as a parameter. Non-pharmaceutical interventions 86 (NPIs) designed to control transmission typically reduce and hence * . We denote 87 the resulting controlled reproduction number by , . The effective reproduction 88 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. 

In a directly transmitted infectious disease, such as variation in exposure 113 to infection is primarily governed by patterns of connectivity among individuals. We 114 incorporate this in the system (Equations 1-4) assuming that individuals mix at 115 random (but see Methods for more general formulations that enable other mixing 116 patterns). Under random mixing and heterogeneous connectivity, the force of 117 infection 7 is written as ( ) = ( ⁄ )( ∫ [ ( ) + ( )] ∫ ( ) ⁄ ), the basic 118 reproduction number is 119

120 , ( ) is as above and -.. ( ) is derived by a more general expression given in 121

Methods. Applying this model to the same epidemics as before we estimate: * 122 rounding 7.1 (Belgium), 3.8 (England), 7.9 (Portugal) and 6.6 (Spain); individual 123 susceptibility CV reaching 2.9 (Belgium), 1.6 (England), 4.0 (Portugal) and 2.7 124 (Spain); and intervention efficacy during lockdown being 73% (Belgium), 58% 125 (England), 80% (Portugal) and 72% (Spain). 126

Comparing the two models, variation in connectivity systematically leads to estimates 127 that are higher for * , lower for CV, and higher for the efficacy of non-128 pharmaceutical interventions. Nevertheless, the percentage of the population required 129 to be immune to curb the epidemic and prevent future waves when interventions are 130 lifted appears remarkably conserved across models: 9.6 vs 11% (Belgium); 20 vs 21% 131 (England); 7.3 vs 6.0% (Portugal); and 12 vs 11% (Spain). This property is further 132 explored below. 133

Herd immunity thresholds and their conserveness across models 134 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 Individual variation in risk of acquiring infection is under selection by the force of 135 infection, whether individual differences are due to biological susceptibility, 136 exposure, or both. The most susceptible or exposed individuals are selectively 137 removed from the susceptible pool as they become infected and eventually recover 138 (some die), resulting in decelerated epidemic growth and accelerated induction of 139 immunity in the population. In essence, the herd immunity threshold defines the 140 percentage of the population that needs to be immune to reverse epidemic growth and 141 prevent future waves. When individual susceptibility or connectivity is gamma-142 distributed and mixing is random, HIT curves can be derived analytically 8 from the 143 model systems (Equations 1-4, with the respective forces of infections). In the case of 144 variation in susceptibility to infection we obtain 145

146 while variable connectivity results in 147

(8) 148

In more complex cases HIT curves can be approximated numerically. Figure 3 shows 149 the expected downward trends in HIT and the sizes of the respective unmitigated 150 epidemics for SARS-CoV-2 without reinfection ( = 0) as the coefficients of 151 variation are increased (gamma distribution shapes adopted here are illustrated in 152 Extended Data Figure 1 ; for robustness of the trends to other distributions see Gomes 153 et al 9 ). Values of * and CV estimated for our study countries are overlaid to mark 154 the respective HIT and final epidemic sizes. While herd immunity is expected to 155 require 60-80% of a homogeneous population to have been infected, at the cost of 156 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 infecting almost the entire population if left unmitigated, given an * between 2.5 and 157 5, these percentages drop to the range 10-20% or lower when CV is roughly between 158 2 and 5. 159

When acquired immunity is not 100% effective ( > 0) HITs are relatively higher 160 (Extended Data Figure 2 ). However, there is an upper bound for how much it is 161 reasonable to increase before the system enters a qualitatively different regime. 162 Above = 1 * ⁄ -the reinfection threshold 10,11 -infection becomes stably endemic 163 and the HIT concept no longer applies. Respiratory viruses are typically associated 164 with epidemic dynamics below the reinfection threshold, characterized by seasonal 165 epidemics intertwined with periods of undetection. 166

Individual variation in exposure, in contrast with susceptibility, accrues from complex 167 patterns of human behaviour which have been simplified in our model. To explore the 168 scope of our results we generalise our models (Methods) by relaxing some key 169 assumptions. First, we enable mixing to be assortative in the sense that individuals 170 contact predominantly with those of similar connectivity. Formally, an individual 171 with connectivity , rather than being exposed uniformly to individuals of all 172 connectivities , has contact preferences described by a normal distribution on the 173 difference − . We find this modification to have negligible effect on HIT 174 (Extended Data Figure 3 ). Second, we allow connectivity distributions to change in 175 shape (not only scale) when subject to social distancing. In particular we modify the 176 model so that CV reduces in proportion to the intensity of social distancing (Extended 177 Data Figure 4 ) and replicate the fittings to epidemics in our study countries (Extended 178 Data Figure 5 ). We find a general tendency for this model to estimate higher values 179 for * and CV while HIT remains again remarkably robust to the change in model 180 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 

Herd immunity thresholds and seroprevalenve at sub-national levels 182

As countries are conducting immunological surveys to assess the extent of exposure 183 to SARS-CoV-2 in populations it is of practical importance to understand how HIT 184 may vary across regions. We have redesigned our analyses to address this question. 185

Series of daily new cases were stratified by region. Fitting the models simultaneously 186 to the multiple series enabled the estimation of local parameters ( * and CV) while 187 the effects of NPIs were estimated at country level. Extended Data Figures 6-9 show 188 how the modelled epidemics fit the regional data and include an additional metric to 189 describe the cumulative infected percentage. These model projections are comparable 190 to data from seroprevalence studies such as Spain 12 . We emphasise that 191 seroprevalence estimates generally lie slightly below our cumulative infection curves 192 (Extended Data Figure 9 ) consistently with recent findings that a substantial fraction 193 of infected individual does not exhibit detectable antibodies 13 . In addition to their 194 practical utility these results begin to unpack some of the variation in HIT within 195 countries: Belgium (9.4-11%), England (16-26%), Portugal (7.1-9.9%) and Spain 196 (7.5-21%). 197

The concept of herd immunity was developed in the context of vaccination 199 programs 14,15 . Defining the percentage of the population that must be immune to 200 cause infection incidences to decline, HITs constitute useful targets for vaccination 201 coverage. In idealized scenarios of vaccines delivered at random and individuals 202 mixing at random, HITs are given by a simple formula (1 − 1 * ⁄ ) which, in the case 203 of SARS-CoV-2, suggests that 60-80% of randomly chosen subjects of the population 204 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.23.20160762 doi: medRxiv preprint would need be immunized to halt spread considering estimates of * between 2.5 and 205 5. This formula does not apply to infection-induced immunity because natural 206 infection does not occur at random. Individuals who are more susceptible or more 207 exposed are more prone to be infected and become immune, providing greater 208 community protection than random vaccination 16 . In our model, the HIT declines 209 sharply when coefficients of variation increase from 0 to 2 and remains below 20% immunogenicity in early-phase clinical trials 17,18 , although it is not yet known how 218 this will translate into effective protection. We note that the reinfection threshold 10,11 219 informs not only the requirements on naturally acquired immunity but, similarly, it 220 sets a target for how efficacious a vaccine needs to be in order to effectively interrupt 221 transmission. Specifically, given an estimated value of * we should aim for a 222 vaccine efficacy of 1 − 1 * ⁄ (60% or 80% if * is 2.5 or 5, respectively). A vaccine 223 whose efficacy is insufficient to bring the system below the reinfection threshold will 224 not interrupt transmission. 225

Heterogeneity in the transmission of respiratory infections has traditionally focused 226 on variation in exposure summarized into age-structured contact matrices. Besides 227 overlooking differences in susceptibility given exposure, the aggregation of 228 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.23.20160762 doi: medRxiv preprint individuals into age groups reduces coefficients of variation. We calculated CV for 229 the landmark POLYMOD matrices 19, 20 and obtained values between 0.3 and 0.5. 230

Recent studies of COVID-19 integrated contact matrices with age-specific 231 susceptibility to infection (structured in three levels) 21 or with social activity (three 232 levels also) 22 which, again, resulted in coefficients of variation less than unity. We 233

show that models with coefficients of variation of this magnitude would appear to 234 differ only moderately from homogeneous approximations when compared with our 235 estimates, which are consistently above 1 in England and above 2 in Belgium, 236

Portugal and Spain. In contrast with reductionistic procedures that aim to reconstruct 237 variation from correlate markers left on individuals (such as antibody or reactive T 238 cells for susceptibility, or contact frequencies for exposure), we have embarked on a 239 holistic approach designed to infer the whole extent of individual variation from the 240 imprint it leaves on epidemic trajectories. Our estimates are therefore expected to be 241 higher and should ultimately be confronted with more direct measurements as these 242 become available. Adam at et 23 conducted a contact tracing study in Hong Kong and 243 estimated a coefficient of variation of 2.5 for the number of secondary infections 244 caused by individuals, attributing 80% of transmission to 20% of cases. This 245 statistical dispersion has been interpreted as reflecting a common pattern of contact 246 heterogeneity which has been corroborated by studies that specifically measure 247 mobility 24 . According to our inferences, 20% of individuals may be responsible for 248 47-94% infections depending on model and country. In parallel, there is accumulating 249 evidence of individual variation in the immune system¢s ability to control SARS-250

CoV-2 infection following exposure 25,26 . While our inferences serve their purpose of 251 improving accuracy in model predictions, diverse studies such as these are necessary 252 for developing interventions targeting individuals who may be at higher risk of being 253 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.23.20160762 doi: medRxiv preprint infected and propagating infection in the community. 254

Country-level estimates of * reported here are in the range 3-5 when individual 255 variation in susceptibility is factored and 4-8 when accounting for variation in 256 connectivity. The homogeneous version of our models would have estimated * 257 between 2.4 and 3.3, in line with other studies 27 . Estimates for England suggest lower 258 baseline * and lower CV in comparison with the other study countries (Belgium, 259 Portugal and Spain). The net effect is a slightly higher HIT in England which 260 nevertheless we estimate around 20%. The lowest HIT, at less than 10%, is estimated 261 in Portugal, with higher * and higher CV. NPIs reveal less impact under variable 262 susceptibility (48-69%), followed by variable connectivity (58-80%), and finally 263 appear to inflate and agree with Flaxman et al 27 when homogeneity assumptions are 264 made (65-89%), although this does not affect the HIT which relates to pre-pandemic 265 societies. 266

More informative than reading these numbers, however, is to look at simulated 267 projections for daily new cases over future months (Figures 1 and 2 ). In all four 268 countries considered here we foresee HIT being achieved between July and October 269 and the COVID-19 epidemic being mostly resolved by the end of 2020. Looking 270 back, we conclude that NPIs had a crucial role in halting the growth of the initial 271 wave between February and April. Although the most extreme lockdown strategies 272 may not be sustainable for longer than a month or two, they proved effective at 273 preventing overshoot, keeping cases within health system capacities, and may have 274 done so without impairing the development of herd immunity. 275 276 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. intervals. Vertical lines represent the expected time when herd immunity threshold 360 will be achieved. Circles depict independent mobility data Google 6 not used in our 361 parameter estimation. 362 363 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. intervals. Vertical lines represent the expected time when herd immunity threshold 380 will be achieved. Circles depict independent mobility data Google 6 not used in our 381 parameter estimation. 382 383 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. Tables 1 and  390 2) assuming gamma-distributed: susceptibility (top); connectivity (bottom). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.23.20160762 doi: medRxiv preprint

Model structure and underlying assumptions 397

The model presented here is a differential equation SEIR model, where susceptible 398 individuals become exposed at a rate that depends on their susceptibility, the number 399 of potentially infectious contacts they engage in, and the total number of infectious 400 people in the population per time unit. Upon exposure, individuals enter an 401 asymptomatic incubation phase, during which they slowly become infectious 29-32 . 402

Thus, infectivity of exposed individuals is made to be 1/2 of that of infectious ones 403 ( = 0.5). After a few days, individuals develop symptoms -on average 4 days after 404 the exposure to the virus ( = 1/4) -and thus become fully infectious 33-35 . They 405 recover, i.e., they are no longer infectious 4 days after that ( = 1/4), on average 36 . 406

We conducted the core of our analysis under the assumption that no reinfection occurs 408 after recovery due to acquired immunity ( = 0). To analyse the sensitivity of these 409 results to leakage in immune response ( > 0) we calculated herd immunity 410 thresholds (HIT) as a function of coefficients of variation (CV) for different values of 411

. The results displayed in Extended Data Figure 2 confirm the expectation that as the 412 efficacy of acquired immunity decreases ( increases) larger percentages of the 413 population are infected before herd immunity is reached. Less intuitive is that there is 414 an upper bound for how much it is reasonable to increase before the system enters a 415 qualitatively different regime -the reinfection threshold 10-11 ( = 1 * ⁄ ) -above 416 which infection becomes stably endemic and the notion of herd immunity threshold 417 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. In the main text we assumed random mixing among individuals, but human 428 connectivity patterns are assortative due societal structures and human behaviours. To 429 explore the sensitivity of our results to deviations from random mixing, we develop 430 an extended formalism that allows individuals to connect preferentially with those 431 with similar connectivity, formally ( ) = 432

is a normal 433 distribution on the difference between connectivity factors (Extended Data Figure 3) . 434

The formulation of the variable connectivity model in the main text assumes that 436 coefficients of variation are constant irrespective of interventions. Social distancing 437 has been assumed to reduce connectivity of every individual by the same factor (from 438 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.23.20160762 doi: medRxiv preprint

The model laid out above is amenable to theoretical exploration as presented in the 462 main manuscript and provides a perfect framework for inference. Fundamentally, to 463 be able to reproduce the inception of any epidemic, we would need to estimate when In order to preserve identifiability, we made two simplifying assumptions: (i) the 474 fraction of infectious individuals reported as COVID-19 cases (reporting fraction) is 475 constant throughout the study period and is comparable between countries 476

proportionally to the number of tests performed per person; (ii) local transmission 477 starts ( * ) when countries/regions report 1 case per 5 million population in one day. 478

To calculate the reporting rates, we used the Spanish national serological survey 12 as a 479 reference and divided the total number of reported cases up to May 11 th by the 480 estimated number of people that had been exposed to the virus. This gives us a 481 reporting rate for Spain around 6%. Unfortunately, there are no other national 482 serological surveys that could inform the proportion of the population infected in 483 other countries, so we had to extrapolate the reporting rate for those. Assuming the 484 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. Whist national case and mortality data is easily available for most countries, more 492 spatially resolute data is difficult to find in the public domain. Thus, we restricted our 493 analysis to countries for which disaggregated regional case data was easily available. 494

We collected the data at two time points. First, we compiled all available data from 495 the day the countries started reporting COVID-19 cases to the initial collection date 496 (May 20 th ) and later collated available data from May 21 st to July 10 th . 497

Parameter estimation was performed with the software Matlab, using PESTO 498 (Parameter EStimation Toolbox) 37 , and assuming the reported case data can be 499 accurately described by a Poisson process. We first fixed the beginning of local 500 transmission (parameter * ) in each data series as the day in which reported cases 501 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . in which ( , ) is the simulated model output number of COVID-19 cases at day 506 (with respect to * ), and is the total number of days included in the analysis for each 507 country. 508 When fitting the model to disaggregated data, we follow the procedure outlined above 509 and estimate region-specific * and , with common * 4 and 567 . To ensure that 510 the estimated maximum is a global maximum, we performed 50 multi-starts 511 optimizations, and selected the combination of parameters resulting in the maximal 512 This fitting procedure was applied to 4 countries (Belgium, England, Portugal and 518 Spain) for both the national and disaggregated case data series and repeated for each 519 of the 4 model variants considered here (homogeneous, heterogeneous susceptibility, 520 heterogeneous connectivity with constant CV, and heterogeneous connectivity with 521 CV reducing in proportion to social distancing). In the fitting procedures using sub-522 national data, we assumed regions had the same start date for interventions that 523 mitigate transmission ( * 4 ), and that these measures produced the same maximum 524 impact on transmission ( . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 Table 5 ). In all cases, heterogeneous models are preferred over the 533 homogeneous approximation. Homogeneous models systematically fail to fit the 534 maintenance of low numbers of cases after the relaxation of social distancing 535 measures in many countries and regions (images not shown). The three heterogeneous 536 models are roughly equally well supported by the data used in this study. Further 537 research should complement this with discriminatory data types and hybrid models to 538 enable the integration of different forms of individual variation. 539

Datasets are publicly available at the respective national ministry of health websites 541 (44) (45) (46) (47) (48) . 542 543 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. 

The authors declare no competing interests. 601 602 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. connectivity. Gamma distribution probability density functions with mean 1 and 606 various coefficients of variation:

is the Gamma function. For numerical implementations we discretized gamma 608 distributions into bins, calculated the susceptibility or connectivity factor as well as 609 the fraction of the population in each bin, and derived the associated 4 -dimensional 610 systems of ordinary differential equations. 611 612 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. Efficacy of acquired immunity is captured by a reinfection parameter , potentially 619 ranging between = 0 (100% efficacy) and = 1 (0 efficacy). This illustration 620 depicts final sizes of unmitigated epidemics and associated HIT curves for 6 values of 621 : = 0 (black); = 0.1 (green); = 0.2 (blue); = 0.3 (magenta); = 1 3 ⁄ (red); 622 and = 0.4 (orange);. Above = 1 * ⁄ (reinfection threshold (Gomes et al 2004;  623 2016)) the infection becomes stably endemic and there is no herd immunity threshold. 624

Representative epidemics of the regime ≤ 1 * ⁄ are shown on the right while the 625 regime > 1 * ⁄ is illustrated on top. All depicted dynamics are based on the 626 rightmost CVs represented on the main panel. 627 628 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 number, coefficients of variation and social distancing parameters estimated by 669

Bayesian inference as described in Methods (estimates in Extended Data Table 3 ). 670

Curves represent mean model predictions from 10 2 posterior samples. Orange shades 671 represent 95% credible intervals. Vertical lines represent the expected time when herd 672 immunity threshold will be achieved. Circles depict independent mobility data 673 (Google 2020) not used in our parameter estimation. 674 675 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020 . . https://doi.org/10.1101 /2020 Table 1 and 2). Curves represent mean model predictions from 10 2 posterior samples. 686

Orange shades represent 95% credible intervals. Red curves represent cumulative 687 infected percentages. 688 689 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10. 1101 /2020 

Estimates generated from model fit to the national datasets are 743 in the grey shaded rows. The remaining rows provide the region-specific estimates

Best parameter estimates are presented as a bold median bounded by the lower and 745 upper ends for the 95% credible interval